Clover Health board member Lee Shapiro to not stand for re-election; Tran to chair committees

CLOVER HEALTH INVESTMENTS, CORP. /DE

Lee Shapiro will not stand for re-election due to American Heart Association chairmanship; departure effective June 10, 2025.
Thomas Tran appointed Chairman of Audit Committee and Nominating & Corporate Governance Committee effective June 10.
No disagreement with company operations; Shapiro will finish his term through the annual meeting.
Board size unchanged at nine; vacancy will be filled as soon as practicable.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Lee A. Shapiro

Director

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Effective: 2025-06-10
Filed: April 22, 2025, 7:59 PM ET

Mr. Shapiro will fulfill the remainder of his term as member of the Board of Directors and the effective date of his departure will be the Company’s Annual Meeting of Shareholders, June 10, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Lee A. Shapiro departed as Director at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: not stand for re-election
Role: Director

Exact text from the filing

Mr. Shapiro will fulfill the remainder of his term as member of the Board of Directors and the effective date of his departure will be the Company’s Annual Meeting of Shareholders, June 10, 2025.

View on SEC.gov

CLOVER HEALTH INVESTMENTS, CORP. /DE filing history →

Source: SEC EDGAR

accession 0001801170-25-000088

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.